For acute low back pain, there is moderate-certainty evidence that nonsteroidal anti-inflammatory drugs are an eff ...

Discover how innovative physical therapy, smart medications, nutrition strategies and mind-body techniques are transforming ...

Discover how neuromuscular retraining techniques reprogram movement patterns to resolve chronic pain, offering longer-lasting ...

Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid ...

The results suggest that nature-based therapies can be used as promising complementary approaches to pain management. The study was recently published in the renowned journal Nature Communications.

In chronic low back pain, botulinum neurotoxin type A improved patients' pain and functional outcomes vs placebo and other local injection therapies.

Latigo Biotherapeutics has secured $150m in a Series B financing round, which will be used to further the development of its ...

New research reveals why women experience chronic pain more frequently than men, uncovering key biological differences in pain processing.

Dr. Deepak Garg - Trusting in a doctor's expertise can lead to better pain management and improved quality of life for those ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...

The Prospera SCS system for pain management relieved pain, improved sleep and reduced opioid use at 24 months, according to ...

MIRA Pharmaceuticals unveils Ketamir-2 topical for neuropathic pain, complementing its oral version. Clinical and preclinical ...